发明名称 |
Use of 5-Thia-1,4-diazabicyclo [4.2.0] octane-3,8-dioxo compounds in antitumor therapy |
摘要 |
The present invention relates to the use of 5-thia-1,4-diazabicycloÄ4.2.0Üoctane-3,8-dioxo compounds of the general formula I, <CHEM> wherein the radicals have the following meanings: R<1> is hydrogen, halogen, R<2> is hydrogen, halogen, amino, PhCH2CONH, PhOCH2CONH, phthalimido, o-MeNHCOC6H4CONH, 3-o-chlorophenyl-5-methyl-isoxazolyl-4-carbonyl amino, R<3> is hydrogen, alkyl, benzyl, a heterocyclic ring e.g. isoxazole, pyrazole, n is 1 or 2. In the application examples of the suppression of uterine cervix carcinoma cells (HeLa) by the use of various substituted 5-thia-1,4-diazabicycloÄ4.2.0Üoctane-3,8-dioxo derivatives are disclosed. |
申请公布号 |
EP0705606(A1) |
申请公布日期 |
1996.04.10 |
申请号 |
EP19950114673 |
申请日期 |
1995.09.18 |
申请人 |
PLIVA, FARMACEUTSKA, KEMIJSKA, PREHRAMBENA I KOZMETICKA INDUSTRIJA DIONICKO DRUSTVO |
发明人 |
KOVACEVIC, MICE, D. SC.;GRDISA, MIRA, D. SC.;PAVELIC, KRESIMIR, D. SC.;HORVATIC, MARJETA, M. SC.;MANDIC, ZORA M. SC.;TOMIC, MIRJANA M. SC.;HERAK, JURE J., D. SC.;LUKIC, IRENA, M. SC. |
分类号 |
C07D513/04;A61K31/495;A61K31/54;A61K31/549;A61P35/00 |
主分类号 |
C07D513/04 |
代理机构 |
|
代理人 |
|
主权项 |
|
地址 |
|